Shu C, Selmanoff M
Department of Physiology, University of Maryland School of Medicine, Baltimore 21201.
Endocrinology. 1988 Jun;122(6):2699-709. doi: 10.1210/endo-122-6-2699.
In the present study, we investigated the ability of phorbol esters to potentiate Ca2+-dependent depolarization-induced release of tritium-labeled dopamine ([3H]DA) from median eminence and striatal synaptosomes. Phorbol esters potentiated [3H]DA release in a concentration-dependent manner in both kinds of dopaminergic nerve terminals and with a potency series similar to that reported for stimulation of protein kinase-C (PKC) activity in other cell systems. Evoked [3H]DA release was increased by 12-O-tetradecanoylphorbol-13-acetate (TPA; 10(-7) M) after 1, 3, 5, and 10 sec of depolarization. The effect of TPA was suppressed by sphingosine, a PKC inhibitor. TPA enhanced [3H]DA release evoked by high K+, veratridine or the Ca2+ ionophore A23187. Phorbol ester potentiation was found to be depolarization dependent, as it was present from 30-75 mM, but not at 5-20 mM external K+. Potentiation was seen at all external Ca2+ concentrations studied between 0.01-3 mM. However, in the absence of external free Ca2+ (i.e. with 0.1 mM EGTA), the phorbol effect was not present. These data indicate that an increase in intrasynaptosomal Ca2+ concentration is necessary for the enhancement of [3H]DA release by phorbol esters to occur. The combination of TPA and the Ca2+ ionophore A23187 does not show the marked synergism observed in some other systems, that is maximal release was not reinstated. This suggests that in dopaminergic nerve terminals, activation of PKC has a modulatory, rather than a mediating, effect on release. Recently, we have shown that hyperprolactinemia stimulated [3H]DA release from median eminence synaptosomes by an external Ca2+-independent mechanism which might involve the PKC pathway. However, in the present work we found that the TPA and PRL effects on evoked [3H]DA release were additive, suggesting that two independent mechanisms are involved. A marked difference in the sensitivity of median eminence and striatal synaptosomes to calcium ionophore was discovered. The concentration of A23187 required to support significant [3H]DA release from median eminence synaptosomes was 3-fold greater than that in striatal synaptosomes. This suggests that some difference in calcium homeostatic processes exists, such as a higher resting striatal Ca2+ concentration, in these two kinds of dopaminergic nerve terminals. These data support the hypothesis that PKC activation potentiates the intrasynaptosomal stimulus-secretion coupling mechanism(s) and that nigrostriatal and tuberoinfundibular dopaminergic nerve terminals are affected by phorbol esters in a similar manner.
在本研究中,我们研究了佛波酯增强钙离子依赖性去极化诱导的来自正中隆起和纹状体突触体的氚标记多巴胺([3H]DA)释放的能力。佛波酯在两种多巴胺能神经末梢中均以浓度依赖性方式增强[3H]DA释放,其效力顺序与其他细胞系统中报道的刺激蛋白激酶-C(PKC)活性的顺序相似。去极化1、3、5和10秒后,12-O-十四烷酰佛波醇-13-乙酸酯(TPA;10(-7) M)可增加诱发的[3H]DA释放。PKC抑制剂鞘氨醇可抑制TPA的作用。TPA增强了高钾、藜芦碱或钙离子载体A23187诱发的[3H]DA释放。发现佛波酯的增强作用依赖于去极化,因为在细胞外钾浓度为(30 - 75 mM)时存在这种作用,而在5 - 20 mM时则不存在。在研究的所有细胞外钙离子浓度(0.01 - 3 mM)下均观察到增强作用。然而,在没有细胞外游离钙离子(即含有0.1 mM乙二醇双乙醚二胺四乙酸(EGTA))的情况下,不存在佛波效应。这些数据表明,突触体内钙离子浓度的增加是佛波酯增强[3H]DA释放所必需的。TPA和钙离子载体A23187的联合使用并未显示出在其他一些系统中观察到的明显协同作用,即未恢复最大释放。这表明在多巴胺能神经末梢中,PKC的激活对释放具有调节作用,而非介导作用。最近,我们已经表明高催乳素血症通过一种可能涉及PKC途径的细胞外钙离子非依赖性机制刺激来自正中隆起突触体的[3H]DA释放。然而,在本研究中我们发现TPA和催乳素对诱发的[3H]DA释放的作用是相加的,这表明涉及两种独立的机制。发现正中隆起和纹状体突触体对钙离子载体的敏感性存在显著差异。支持从正中隆起突触体显著释放[3H]DA所需的A23187浓度比纹状体突触体中的高3倍。这表明在这两种多巴胺能神经末梢中,钙稳态过程存在一些差异,例如纹状体的静息钙离子浓度较高。这些数据支持以下假设:PKC的激活增强了突触体内的刺激 - 分泌偶联机制,并且黑质纹状体和结节漏斗多巴胺能神经末梢以相似的方式受到佛波酯的影响。